Global Electronic Trial Master File (eTMF) Systems market is expected to witness a growth of CAGR 12% by 2027

Increasing number of clinical trials, a surge in the volume of data generated, and an increase in the number of eTMF system users are some of the key factors driving the eTMF systems market. However, inadequate trained professionals and clinical data privacy are some of the challenges that are likely to hamper the global eTMF Systems Market growth.

(firmenpresse) - Electronic Trial Master File (eTMF) is a content management system for the Bio-Pharma industry which includes protocols, strategies, and tools used throughout the lifecycle of the clinical trial. An eTMF digitally captures, shares, and stores the essential documents and content generated in a clinical trial.

Increasing Adoption due to benefits Offered by eTMF Systems drive the Electronic Trial Master File (eTMF) Systems
Post Covid-19 pandemic, the number of clinical trials and volume of data generated increased exponentially, which in turn has fueled the adoption of eTMF systems by Bio-Pharma companies. The eTMF systems give real-time visibility of the clinical trial data and activities conducted at scattered sites across the globe. The benefits of adopting eTMF are increased business efficiency, speedup timelines, reduced cost and risk.

For instance,

?In June 2022, Anju Software Inc., announced the introduction of its new cloud-based eTMF product. The product will expedite the collaboration between CRO’s, sponsor and sites to manage the clinical data efficiently in a regulatory-compliant environment

Resurgence of Electronic Trial Master File (eTMF) Systems Post Pandemic Drives the Electronic Trial Master File (eTMF) Systems Market
The Covid-19 Pandemic has triggered a change in execution of the clinical trials. Due to travel bans and lockdowns, virtual clinical trials were initiated by Bio-Pharma companies by adopting remote patient monitoring, telehealth, wearable devices and apps to ensure the patient safety. The vast number of clinical trials conducted for rapid development of vaccines during the pandemic had also burdened the healthcare sector. With rise in the number of trials and its data, there was a shift from manual TMF systems to eTMF systems, for seamless management of data in decentralized clinical trials. The other factor which had set in motion this shift was the clinical data retention regulation policy to maintain the data for 25 years by the Sponsors/CRO’s.



North America Expected to Continue to Hold a Major Share in the Electronic Trial Master File (eTMF) Systems Market
From a geographical perspective, North America holds a major market share of the Electronic Trial Master File (eTMF) Systems market. This can be Primarily attributed to the growing number of clinical trials & volume of data generated, favorable funding environment to support clinical trials, well-developed healthcare IT infrastructure, and presence of several key players in the region However, the Asia-Pacific region is expected to witness strong growth in the coming years due to flourishing Biopharma industry, growing outsourcing of clinical trials in the region, and rapid development of vaccines by Biopharma industry due to Covid-19 Pandemic.

Competitive Landscape : Electronic Trial Master File (eTMF) Systems Marke
Some of the key players operating in the market include Veeva Systems, Aris Global LLC, Master Control, Inc., Montrium, Clinevo Technology, Oracle Corporation, Phlexglobal, Transperfect, Aurea Software, Labcorp (Covance, Inc.) and Sureclinical, among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Electronic Trial Master File (eTMF) Systems Market
The players operating in this market are adopting organic and inorganic growth strategies such as launching new products/technologies, collaborations, and acquisitions to garner higher market share.

For instance,

?In February 2023, TransPerfect Life Sciences announced that Surrozen has selected its Trial Interactive eClinical platform, including electronic Trial Master File (eTMF) and TMF solutions to create a centralized, quality-focused approach to TMF management

The Electronic Trial Master File (eTMF) Systems is a growing market that is expected to gain further momentum in the coming years with growing adoption of the eTMF systems, rising R&D investments by pharma-biotech companies, favorable government funding & grants to support clinical trials, and aggressive organic and inorganic growth strategies followed by the players.
Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: Prathamesh
Datum: 07.08.2023 - 12:34 Uhr
Sprache: Deutsch
News-ID 2058053
Anzahl Zeichen: 4657

Kontakt-Informationen:
Ansprechpartner: Prathamesh Medi Tech
Stadt:

Brussels

Telefon: 0498868079

Kategorie:

Gesundheitswesen - Medizin

Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 07.08.2023

Diese Pressemitteilung wurde bisher 607 mal aufgerufen.

Growing Focus on Augmented Reality Spurs 13% CAGR in Global Bionic Contact Lense ...

Bionic contact lenses are an innovative blend of traditional contact lenses and advanced tech, promising to reshape vision correction and AR experiences by overlaying digital information in real time. They offer benefits such as addressing nearsighte ...

The Bioburden Testing Market Continues Upward Trend with a Projected 12-15% CAGR ...

Bioburden testing, an essential quality control process in pharmaceutical and medical device production, evaluates microbial contamination levels on products, raw materials, and manufacturing settings, including bacteria, fungi, yeasts, and molds. Th ...

The Cardiac Resuscitation Devices Market is Poised to achieve a CAGR of 6-7% by ...

Cardiopulmonary resuscitation (CPR), another name for cardiac resuscitation, is an emergency treatment given to people who are experiencing cardiac arrest—a condition in which the heart stops beating efficiently—in an emergency. In order to susta ...

Alle Meldungen von Medi-tech insights